Glofitamab Treatment for DLBCL Shows Cost Savings Over Epcoritamab in US Healthcare
An economic model reveals glofitamab offers DLBCL patient cost savings versus epcoritamab, despite higher adverse event and treatment administration costs.
Coalition Plans Tree Planting in West Oakland
West Oakland organizations have received $800,000 to plant 1,500 trees, aiming to improve the environment, air…
Doximity Acquires AI Startup Pathway Medical for $63M to Boost Clinical Tools
Doximity acquires AI startup Pathway Medical for $63M to enhance clinical reference tooling and answer doctors'…
Latest Effort by Administration to Curb Federal Power and Spending
Latest administration move limits power of civil servants, tightens federal payment reins after Trump's team actions.
5 Reasons to Feed Your Kids’ Guests
Feeding Your Kids' Friends: What You Need to Know
Feeding Your Kids' Friends: What You Need to Know
Are…
Dynamic Duo Launches First D1 Training Studio in Midway Hollow
Introducing D1 Training's New Fitness Enrichment Concept in Park Cities
Athlete-based fitness training is taking a…
Maine’s ‘Solar for All’ Program Faces Risk Again
Maine's Solar for All program could be jeopardized by Trump administration's plans to end program-funding grants.
Kari Lake & Katie Hobbs Discuss ASU’s 2022 Debate Crisis –…
Kari Lake accuses Arizona State University and Arizona PBS of meddling in 2022 gubernatorial election, favoring…
Buy Now, Pay Later Services Reported to Credit Bureaus Amid Evolving Models
Affirm is now reporting customer repayment data to credit bureaus, reflecting evolving credit scoring models as…
GSA and OpenAI Partner to Accelerate AI Adoption Across Federal Government
The US GSA and OpenAI have announced a groundbreaking partnership to provide best-in-class AI tech to the federal government.